Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-029739
Filing Date
2025-06-05
Accepted
2025-06-05 17:12:04
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749157895.html 4  
1 FORM 4 wk-form4_1749157895.xml 4 3443
  Complete submission text file 0001628280-25-029739.txt   4906
Mailing Address C/O ARRAY BIOPHARMA INC. 3200 WALNUT STREET BOULDER CO 80301
Business Address
Sandor Victor (Reporting) CIK: 0001620368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 251028103

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Issuer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)